PhilipMerleSpanheimerMD

PubMed

• Role of minimally invasive surgery in the management of localized pancreatic ductal adenocarcinoma: a review.
  Kakati, R., Naffouje, S., Spanheimer, P., Dahdaleh, F.> ;Journal of Robotic Surgery. 2024 Feb 22
• 1 citations
  Cell cycle plasticity underlies fractional resistance to palbociclib in ER+/HER2- breast tumor cells.
  Zikry, T., Wolff, S., Ranek, J., Davis, H., Naugle, A., Luthra, N., Whitman, A., Kedziora, K., Stallaert, W., Kosorok, M., Purvis, J., Spanheimer, P.> ;Proceedings of the National Academy of Sciences of the United States of America. 2024 Feb 13
• Genetic Ancestry-specific Molecular and Survival Differences in Admixed Patients With Breast Cancer.
  Aristeidis G Telonis, Daniel A Rodriguez, Philip M Spanheimer, Maria E Figueroa, Neha Goel> ;Annals of Surgery. 2024 May 1
• Tamoxifen Response at Single-Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors.
  Hyunsoo Kim, Austin A Whitman, Kamila Wisniewska, Rasha T Kakati, Susana Garcia-Recio, Benjamin C Calhoun, Hector L Franco, Charles M Perou, Philip M Spanheimer> ;Clinical Cancer Research. 2023 Dec 1
• Omission of Axillary Dissection in Node Positive Breast Cancer After Neoadjuvant Systemic Therapy.
  Gray B Peery, Joyce Pak, Laura Burkbauer, Chris B Agala, Julia M Selfridge, Kristalyn K Gallagher, Philip M Spanheimer> ;The Journal of Surgical Research. 2023 Dec 1
• Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers.
  Hyunsoo Kim, Kamila Wisniewska, Matthew J Regner, Aatish Thennavan, Philip M Spanheimer, Hector L Franco> ;International Journal of Molecular Sciences. 2023 Aug 22
• Advances in the Management of Early-Stage Triple-Negative Breast Cancer.
  Prarthna V Bhardwaj, Yue Wang, Elizabeth Brunk, Philip M Spanheimer, Yara G Abdou> ;International Journal of Molecular Sciences. 2023 Aug 5
• 1 citations
  Tamoxifen Response at Single Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors.
  Hyunsoo Kim, Austin A Whitman, Kamila Wisniewska, Rasha T Kakati, Susana Garcia-Recio, Benjamin C Calhoun, Hector L Franco, Charles M Perou, Philip M Spanheimer> ;Biorxiv. 2023 Apr 19
• 1 citations
  High expression of the RET receptor tyrosine kinase and its ligand GDNF identifies a high-risk subset of estrogen receptor positive breast cancer.
  Rasha T Kakati, Hyunsoo Kim, Austin Whitman, Philip M Spanheimer> ;Breast Cancer Research and Treatment. 2023 Jun 1
• ASO Visual Abstract: Can We Forego Sentinel Lymph Node Biopsy in Women ≥50 Years of Age with Early-Stage Hormone Receptor-Positive HER2-Negative Special Histologic Sub...
  Nicole Knape, Ji-Hye Park, Chris B Agala, Philip Spanheimer, Monica Morrow, Stephanie Downs-Canner, Xavier L Baldwin> ;Annals of Surgical Oncology. 2023 Feb 1
• 3 citations
  Can We Forgo Sentinel Lymph Node Biopsy in Women Aged ≥ 50 Years with Early-Stage Hormone-Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer?
  Nicole Knape, Ji-Hye Park, Chris B Agala, Philip Spanheimer, Monica Morrow, Stephanie Downs-Canner, Xavier L Baldwin> ;Annals of Surgical Oncology. 2023 Feb 1
• 3 citations
  A Review of Immune Checkpoint Blockade for the General Surgeon.
  Xavier L Baldwin, Philip M Spanheimer, Stephanie Downs-Canner> ;The Journal of Surgical Research. 2023 Jan 1
• Breast surgery after neoadjuvant chemotherapy: time for a change?
  Philip M Spanheimer, Katherine E Reeder-Hayes> ;The Lancet. Oncology. 2022 Dec 1
• ASO Visual Abstract: Prevalence of Pathologic N2/N3 Disease in Postmenopausal Women with Clinical N0 ER+/HER2- Breast Cancer.
  Maire J Amlicke, Jihye Park, Chris B Agala, Dana L Casey, Emily M Ray, Stephanie M Downs-Canner, Philip M Spanheimer> ;Annals of Surgical Oncology. 2022 Nov 1
• 5 citations
  Prevalence of Pathologic N2/N3 Disease in Postmenopausal Women with Clinical N0 ER+/HER2- Breast Cancer.
  Maire J Amlicke, Jihye Park, Chris B Agala, Dana L Casey, Emily M Ray, Stephanie M Downs-Canner, Philip M Spanheimer> ;Annals of Surgical Oncology. 2022 Nov 1
• ASO Author Reflections: Can Genomic Recurrence Score Replace SLNB in Postmenopausal Women with ER+/HER2- Breast Cancer?
  Maire J Amlicke, Philip M Spanheimer> ;Annals of Surgical Oncology. 2022 Nov 1
• 6 citations
  Tumor Grade Predicts for Calcitonin Doubling Times and Disease-Specific Outcomes After Resection of Medullary Thyroid Carcinoma.
  Aradhya Nigam, Bin Xu, Philip M Spanheimer, Ian Ganly, R Michael Tuttle, Richard J Wong, Ashok R Shaha, Ronald A Ghossein, Brian R Untch> ;Thyroid. 2022 Oct 1
• 3 citations
  Pathologic complete response and survival after neoadjuvant chemotherapy in cT1-T2/N0 HER2+ breast cancer.
  Selena J An, Emilie D Duchesneau, Paula D Strassle, Katherine Reeder-Hayes, Kristalyn K Gallagher, David W Ollila, Stephanie M Downs-Canner, Philip M Spanheimer> ;NPJ Breast Cancer. 2022 May 12
• 1 citations
  Does Angiosarcoma of the Breast Need Nodal Staging?
  Joshua Herb, Ugwuji N Maduekwe, Neha Goel, Laura H Rosenberger, Philip M Spanheimer> ;Journal of the American College of Surgeons. 2022 May 1
• 2 citations
  Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer.
  Emilie D Duchesneau, Selena J An, Paula D Strassle, Katherine E Reeder-Hayes, Kristalyn K Gallagher, David W Ollila, Stephanie M Downs-Canner, Philip M Spanheimer> ;Annals of Surgical Oncology. 2022 May 1
• 8 citations
  The impact of age and nodal status on variations in oncotype DX testing and adjuvant treatment.
  Kathleen Iles, Mya L Roberson, Philip Spanheimer, Kristalyn Gallagher, David W Ollila, Paula D Strassle, Stephanie Downs-Canner> ;NPJ Breast Cancer. 2022 Mar 1
• 1 citations
  Dosimetric and Clinical Factors Associated With Breast Reconstruction Complications in Patients Receiving Postmastectomy Radiation.
  Jacob Hall, David Fried, Lawrence B Marks, Gaorav P Gupta, Ellen Jones, Shekinah Elmore, Kevin Pearlstein, Stephanie Downs-Canner, Kristalyn Gallagher, Philip M Spanhe...> ;Practical Radiation Oncology. 2021 Dec 14
• 32 citations
  International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma
  Bin Xu, Talia L Fuchs, Sara Ahmadi, Mohammed Alghamdi, Bayan Alzumaili, Mohamed-Amine Bani, Eric Baudin, Angela Chou, Antonio De Leo, James A. Fagin, Ian Ganly, Anthon...> ;Journal of Clinical Oncology. 2021 Nov 3
• 1 citations
  Bridging Endocrine Therapy for HR+/HER2- Resectable Breast Cancer: Is it Safe?
  Kathleen Iles, Madeline Thornton, Jihye Park, Mya L. Roberson, Philip M Spanheimer, David W. Ollila, Kristalyn K. Gallagher> ;The American Surgeon. 2021 Sep 29
• 5 citations
  A Pilot Study of Preoperative Vandetanib on Markers of Proliferation and Apoptosis in Breast Cancer.
  Philip M Spanheimer, Amani Bashir, Allison W. Lorenzen, Anna C. Beck, Junlin Liao, Ingrid Lizarraga, Lillian M. Erdahl, Sonia L. Sugg, Mark Karwal, Ronald J. Weigel> ;American Journal of Clinical Oncology. 2021 Sep 1
• Join now to see all